Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion type Assertion NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_head.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_provenance.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion evidence source_evidence_literature NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_provenance.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion SIO_000772 22210719 NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_provenance.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion wasDerivedFrom befree-20150227 NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_provenance.
- NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_assertion wasGeneratedBy ECO_0000203 NP817190.RAOtxkQdN-8nKXnE2gfSRu_o7jbW_OimJZz1qy5BA8sHI130_provenance.